Cargando…

Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?

BACKGROUND: In response to the high financial burden of health services facing tuberculosis (TB) patients in China, the China-Gates TB project, Phase II, has implemented a new financing and payment model as an important component of the overall project in three cities in eastern, central and western...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wei-Xi, Long, Qian, Lucas, Henry, Dong, Di, Chen, Jia-Ying, Xiang, Li, Li, Qiang, Huang, Fei, Wang, Hong, Elbers, Chris, Cobelens, Frank, Tang, Sheng-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431427/
https://www.ncbi.nlm.nih.gov/pubmed/30904025
http://dx.doi.org/10.1186/s40249-019-0532-x
_version_ 1783405921819426816
author Jiang, Wei-Xi
Long, Qian
Lucas, Henry
Dong, Di
Chen, Jia-Ying
Xiang, Li
Li, Qiang
Huang, Fei
Wang, Hong
Elbers, Chris
Cobelens, Frank
Tang, Sheng-Lan
author_facet Jiang, Wei-Xi
Long, Qian
Lucas, Henry
Dong, Di
Chen, Jia-Ying
Xiang, Li
Li, Qiang
Huang, Fei
Wang, Hong
Elbers, Chris
Cobelens, Frank
Tang, Sheng-Lan
author_sort Jiang, Wei-Xi
collection PubMed
description BACKGROUND: In response to the high financial burden of health services facing tuberculosis (TB) patients in China, the China-Gates TB project, Phase II, has implemented a new financing and payment model as an important component of the overall project in three cities in eastern, central and western China. The model focuses on increasing the reimbursement rate for TB patients and reforming provider payment methods by replacing fee-for-service with a case-based payment approach. This study investigated changes in out-of-pocket (OOP) health expenditure and the financial burden on TB patients before and after the interventions, with a focus on potential differential impacts on patients from different income groups. METHODS: Three sample counties in each of the three prefectures: Zhenjiang, Yichang and Hanzhong were chosen as study sites. TB patients who started and completed treatment before, and during the intervention period, were randomly sampled and surveyed at the baseline in 2013 and final evaluation in 2015 respectively. OOP health expenditure and percentage of patients incurring catastrophic health expenditure (CHE) were calculated for different income groups. OLS regression and logit regression were conducted to explore the intervention’s impacts on patient OOP health expenditure and financial burden after adjusting for other covariates. Key-informant interviews and focus group discussions were conducted to understand the reasons for any observed changes. RESULTS: Data from 738 (baseline) and 735 (evaluation) patients were available for analysis. Patient mean OOP health expenditure increased from RMB 3576 to RMB 5791, and the percentage of patients incurring CHE also increased after intervention. The percentage increase in OOP health expenditure and the likelihood of incurring CHE were significantly lower for patients from the highest income group as compared to the lowest. Qualitative findings indicated that increased use of health services not covered by the standard package of the model was likely to have caused the increase in financial burden. CONCLUSIONS: The implementation of the new financing and payment model did not protect patients, especially those from the lowest income group, from financial difficulty, due partly to their increased use of health service. More financial resources should be mobilized to increase financial protection, particularly for poor patients, while cost containment strategies need to be developed and effectively implemented to improve the effective coverage of essential healthcare in China. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40249-019-0532-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6431427
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64314272019-04-04 Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor? Jiang, Wei-Xi Long, Qian Lucas, Henry Dong, Di Chen, Jia-Ying Xiang, Li Li, Qiang Huang, Fei Wang, Hong Elbers, Chris Cobelens, Frank Tang, Sheng-Lan Infect Dis Poverty Research Article BACKGROUND: In response to the high financial burden of health services facing tuberculosis (TB) patients in China, the China-Gates TB project, Phase II, has implemented a new financing and payment model as an important component of the overall project in three cities in eastern, central and western China. The model focuses on increasing the reimbursement rate for TB patients and reforming provider payment methods by replacing fee-for-service with a case-based payment approach. This study investigated changes in out-of-pocket (OOP) health expenditure and the financial burden on TB patients before and after the interventions, with a focus on potential differential impacts on patients from different income groups. METHODS: Three sample counties in each of the three prefectures: Zhenjiang, Yichang and Hanzhong were chosen as study sites. TB patients who started and completed treatment before, and during the intervention period, were randomly sampled and surveyed at the baseline in 2013 and final evaluation in 2015 respectively. OOP health expenditure and percentage of patients incurring catastrophic health expenditure (CHE) were calculated for different income groups. OLS regression and logit regression were conducted to explore the intervention’s impacts on patient OOP health expenditure and financial burden after adjusting for other covariates. Key-informant interviews and focus group discussions were conducted to understand the reasons for any observed changes. RESULTS: Data from 738 (baseline) and 735 (evaluation) patients were available for analysis. Patient mean OOP health expenditure increased from RMB 3576 to RMB 5791, and the percentage of patients incurring CHE also increased after intervention. The percentage increase in OOP health expenditure and the likelihood of incurring CHE were significantly lower for patients from the highest income group as compared to the lowest. Qualitative findings indicated that increased use of health services not covered by the standard package of the model was likely to have caused the increase in financial burden. CONCLUSIONS: The implementation of the new financing and payment model did not protect patients, especially those from the lowest income group, from financial difficulty, due partly to their increased use of health service. More financial resources should be mobilized to increase financial protection, particularly for poor patients, while cost containment strategies need to be developed and effectively implemented to improve the effective coverage of essential healthcare in China. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40249-019-0532-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-24 /pmc/articles/PMC6431427/ /pubmed/30904025 http://dx.doi.org/10.1186/s40249-019-0532-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jiang, Wei-Xi
Long, Qian
Lucas, Henry
Dong, Di
Chen, Jia-Ying
Xiang, Li
Li, Qiang
Huang, Fei
Wang, Hong
Elbers, Chris
Cobelens, Frank
Tang, Sheng-Lan
Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?
title Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?
title_full Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?
title_fullStr Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?
title_full_unstemmed Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?
title_short Impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?
title_sort impact of an innovative financing and payment model on tuberculosis patients’ financial burden: is tuberculosis care more affordable for the poor?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431427/
https://www.ncbi.nlm.nih.gov/pubmed/30904025
http://dx.doi.org/10.1186/s40249-019-0532-x
work_keys_str_mv AT jiangweixi impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT longqian impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT lucashenry impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT dongdi impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT chenjiaying impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT xiangli impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT liqiang impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT huangfei impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT wanghong impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT elberschris impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT cobelensfrank impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor
AT tangshenglan impactofaninnovativefinancingandpaymentmodelontuberculosispatientsfinancialburdenistuberculosiscaremoreaffordableforthepoor